A Compassionate Use (CU) Program of Odronextamab

Sponsor: Regeneron Pharmaceuticals

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT05619367

This compassionate use program provides access to odronextamab, a drug intervention, for patients who meet specific eligibility criteria. The program is designed for individuals with serious or life-threatening conditions who have exhausted other treatment options. Participants must adhere to the outlined medical and safety requirements to qualify for this compassionate use initiative.

Patient Parameters

Program Overview

Provide compassionate use of odronextamab

Eligibility Criteria

Get This Program In Your Inbox

You can sign up and apply your patients for this program.